Severe DRESS Syndrome Managed With Therapeutic Plasma Exchange

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but increasingly described phenomenon of immune activation and organ dysfunction in association with a wide variety of medications. This reaction shows a broad spectrum of clinical presentation and severity, ranging from mild to lethal. Treatment strategies of immune suppression appear be helpful in some cases, but treatment failures occur frequently with reported mortality rates of 5% to 10%. We present a pediatric case of DRESS syndrome associated with either lamotrigine or bupropion, leading to multiorgan involvement and life-threatening complications of respiratory failure and cardiac arrest. After failing to improve with removal of these medications and administration of systemic corticosteroids, our patient showed dramatic, sustained clinical response to therapeutic plasma exchange. To our knowledge, this is the first reported case of therapeutic plasma exchange used for life-threatening DRESS syndrome in a pediatric patient. This case suggests needed research for this therapeutic option in life-threatening DRESS syndrome resistant to high-dose steroids.

[1]  R. Okuyama,et al.  Clinical course of drug‐induced hypersensitivity syndrome treated without systemic corticosteroids , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  M. Neuman,et al.  The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation , 2012, International journal of hepatology.

[3]  B. Janela,et al.  Poor benefit/risk balance of intravenous immunoglobulins in DRESS. , 2011, Archives of dermatology.

[4]  Y. Tokura,et al.  High-dose intravenous immunoglobulin monotherapy for drug-induced hypersensitivity syndrome. , 2012, Acta dermato-venereologica.

[5]  D. Creamer,et al.  Ten cases of drug reaction with eosinophilia and systemic symptoms (DRESS) treated with pulsed intravenous methylprednisolone. , 2011, European journal of dermatology : EJD.

[6]  J. Roujeau,et al.  The DRESS syndrome: a literature review. , 2011, The American journal of medicine.

[7]  B. K. Park,et al.  Immune pathomechanism of drug hypersensitivity reactions. , 2011, The Journal of allergy and clinical immunology.

[8]  M. Tohyama,et al.  New aspects of drug‐induced hypersensitivity syndrome , 2011, The Journal of dermatology.

[9]  A. Mercat,et al.  First Report of Lamotrigine-Induced Drug Rash with Eosinophilia and Systemic Symptoms Syndrome with Pancreatitis , 2010, The Annals of pharmacotherapy.

[10]  B. Janela,et al.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Multiorgan Antiviral T Cell Response , 2010, Science Translational Medicine.

[11]  F. Bridoux,et al.  Cyclophosphamide therapy for corticoresistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a patient with severe kidney and eye involvement and Epstein-Barr virus reactivation. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  J. Herre,et al.  Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis. , 2010, Journal of the American Academy of Dermatology.

[13]  Susun Bellew,et al.  Twelve-Year Analysis of Severe Cases of Drug Reaction With Eosinophilia and Systemic Symptoms: A Cause of Unpredictable Multiorgan Failure , 2010 .

[14]  P. Musette,et al.  Severe vancomycin-induced drug rash with eosinophilia and systemic symptoms syndrome imitating septic shock. , 2009, European journal of anaesthesiology.

[15]  T. Shiohara,et al.  The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. , 2009, Immunology and allergy clinics of North America.

[16]  V. Paradis,et al.  Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. , 2009, Archives of dermatology.

[17]  M. Amante,et al.  Dress syndrome and fulminant hepatic failure induced by lamotrigine. , 2009, Annals of hepatology.

[18]  M. Beyens,et al.  Serious Adverse Reactions of Bupropion for Smoking Cessation , 2008, Drug safety.

[19]  O. Ramilo,et al.  Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection. , 2007, The Pediatric infectious disease journal.

[20]  Z. Ikezawa,et al.  The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations , 2007, The British journal of dermatology.

[21]  M. Mockenhaupt,et al.  Variability in the clinical pattern of cutaneous side‐effects of drugs with systemic symptoms: does a DRESS syndrome really exist? , 2007, The British journal of dermatology.

[22]  T. Shiohara,et al.  Several herpesviruses can reactivate in a severe drug‐induced multiorgan reaction in the same sequential order as in graft‐versus‐host disease , 2006, The British journal of dermatology.

[23]  P. Demoly,et al.  Variability in the clinical pattern of cutaneous side‐effects of drugs with systemic symptoms: does a DRESS syndrome really exist? , 2006, The British journal of dermatology.

[24]  T. Shiohara,et al.  Drug-induced Hypersensitivity Syndrome(DIHS): A Reaction Induced by a Complex Interplay among Herpesviruses and Antiviral and Antidrug Immune Responses. , 2006, Allergology international : official journal of the Japanese Society of Allergology.

[25]  C. Marone,et al.  Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment. , 2005, Clinical nephrology.

[26]  E. Chiao,et al.  Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG). , 2005, Journal of drugs in dermatology : JDD.

[27]  T. Shiohara,et al.  Sequential reactivation of herpesvirus in drug-induced hypersensitivity syndrome. , 2004, Acta dermato-venereologica.

[28]  Y. Yamakawa,et al.  Carbamazepine‐induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real‐time quantitative polymerase chain reaction , 2003, The British journal of dermatology.

[29]  K. Harman,et al.  Persistent anticonvulsant hypersensitivity syndrome responding to ciclosporin , 2003, Clinical and experimental dermatology.

[30]  R. Bardenstein,et al.  Human parvovirus B19 infection in children: uncommon clinical presentations. , 2002, The Israel Medical Association journal : IMAJ.

[31]  M. Pirmohamed,et al.  Are chemically reactive metabolites responsible for adverse reactions to drugs? , 2002, Current drug metabolism.

[32]  R. Busund,et al.  Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial , 2002, Intensive Care Medicine.

[33]  B. Crickx,et al.  Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. , 2001, Archives of dermatology.

[34]  D. Descamps,et al.  [Parvovirus B19 infection mimicking drug-induced hypersensitivity syndrome]. , 2000, Annales de dermatologie et de venereologie.

[35]  E. Mylonakis,et al.  Lamotrigine Overdose Presenting as Anticonvulsant Hypersensitivity Syndrome , 1999, The Annals of pharmacotherapy.

[36]  J. Roujeau,et al.  Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug‐induced hypersensitivity syndrome , 1998, The British journal of dermatology.

[37]  R. Sontheimer,et al.  DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome. , 1998, Archives of dermatology.

[38]  J. Roujeau,et al.  [Hypersensitivity syndrome during Mycoplasma pneumoniae infection]. , 1998, Annales de dermatologie et de venereologie.

[39]  H. Moriwaki,et al.  Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. , 1998, Critical care medicine.

[40]  J. V. D. van der Meer,et al.  Plasma patterns of tumor necrosis factor-alpha (TNF) and TNF soluble receptors during acute meningococcal infections and the effect of plasma exchange. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  J. Roujeau,et al.  Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). , 1996, Seminars in cutaneous medicine and surgery.

[42]  D. Grant,et al.  Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. , 1986, Annals of internal medicine.

[43]  L. Ackerman,et al.  Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically and pathologically malignant lymphomas , 1959, Cancer.